Pinar Bayrak-Toydemir,
MD, PhD
Languages Spoken: English, Turkish
Dr. Bayrak-Toydemir has focused her research efforts on understanding the molecular genetic characteristics of inherited vascular diseases. She primarily studies Hereditary Hemorrhagic Telangiectasia (HHT) disease. In addition to HHT, her research aims to identify genes that cause various inherited vascular malformations.
Dr. Bayrak-Toydemir is also interested in application of array technology and next generation sequencing to molecular diagnostics. Specifically, she has focused on detecting molecular genetic causes of mental retardation syndromes.
Specialties
Board Certification and Academic Information
| Academic Departments | Pathology
-
Professor Pediatrics - Adjunct Associate Professor |
| Academic Divisions | Clinical Pathology Pediatric Genetics |
| Board Certification | American Board of Medical Genetics (Clinical Molecular Genetics) American Board of Medical Genetics (Clinical Molecular Genetics) |
Dr. Bayrak-Toydemir is a medical director of the Molecular Genetics and Genomics Department at ARUP and an associate professor of clinical pathology at the University of Utah’s School of Medicine. Dr. Bayrak-Toydemir received her PhD in human genetics at the Ankara University School of Medicine and completed a fellowship in clinical molecular genetics at the University of Utah School of Medicine. She is certified with the American Board of Medical Genetics; and a member of the American Society of Human Genetics, Hereditary Hemorrhagic Telangiectasia Foundation International, Inc., and the Turkish Society of Medical Genetics.
Academic Locations
ARUP Laboratories
801-583-2787-Ext-3171
Board Certification and Academic Information
| Academic Departments | Pathology
-
Professor Pediatrics - Adjunct Associate Professor |
| Academic Divisions | Clinical Pathology Pediatric Genetics |
| Board Certification | American Board of Medical Genetics (Clinical Molecular Genetics) American Board of Medical Genetics (Clinical Molecular Genetics) |
Research Interests
The effect of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothrombin gene G20210A mutations in the genesis of deep vein thrombosis in Behcet's disease patients.
- Molecular Genetics
- Telangiectasia, Hereditary Hemorrhagic
Education History
| Fellowship | University of Utah School of Medicine Clinical Molecular Genetics Fellow |
| Doctoral Training | Ankara University School of Medicine, Medical Biology Department Human Genetics Division Ph.D. |
| Professional Medical | Ankara University School of Medicine Medicine M.D. |
Global Impact
Education History
| Doctoral Training | Ankara University School of Medicine, Medical Biology Department Human Genetics Division Ph.D. |
| Professional Medical | Ankara University School of Medicine Medicine M.D. |
Career
| Centre National de la Recherche Scientifique, Unite' de Recherche Associee 1335, Faculte de Medecine Necker-Enfants Malades | Visiting Scientist | France |
| Turkish Republic Ministry of Health Ankara Hospital, Emergency Medicine Department | General Practitioner | Turkey |
| Ankara University School of Medicine, Medical Biology Department | Research and Teaching Assistant | Turkey |